Mortality due to KPC carbapenemase-producing Klebsiella pneumoniae infections: Systematic review and meta-analysis: Mortality due to KPC Klebsiella pneumoniae infections. 2018

Jorge A Ramos-Castañeda, and Alberto Ruano-Ravina, and Raquel Barbosa-Lorenzo, and Jaime E Paillier-Gonzalez, and Javier C Saldaña-Campos, and Diego F Salinas, and Elkin V Lemos-Luengas
Graduate School, Universidad CES, Medellín, Colombia. Electronic address: jormos2806@gmail.com.

KPC carbapenemase-producing Klebsiella pneumoniae (KPC-KP) has become a major public health challenge. Accordingly, this study sought to use a systematic review of the scientific literature to ascertain the mortality of KPC-KP infection, and analyze such mortality by country, year of publication, hospital ward, and type of interpretation used to define carbapenem resistance. A search without language restrictions was made of the MEDLINE, CENTRAL, EBSCO, LILACS and EMBASE databases from 1996 through June 2017, to locate all studies which had determined the existence of KPC-KP infection. We then performed a meta-analysis of all studies that reported KPC-KP infection-related mortality, and analyzed mortality by subgroup in accordance with standard methodology. A total of 51 papers were included in the systematic review. From 2005 through 2017, data on KPC-KP infection were reported in 5124 patients, with an average of 465 patients per year. The most widely studied type of infection was bacteremia (28∙0%). The meta-analysis showed that overall mortality for the 37 studies was 41.0% (95%CI 37.0-44.0), with the highest mortality rates being observed in oncology patients, 56.0% (95%CI 38.1-73.0), and Brazil, 51.3% (95%CI 43.0-60.0). KPC-KP infection-related mortality is high, is manifested differently in some countries, and is highest among oncology patients.

UI MeSH Term Description Entries
D007710 Klebsiella Infections Infections with bacteria of the genus KLEBSIELLA. Infections, Klebsiella,Infection, Klebsiella,Klebsiella Infection
D007711 Klebsiella pneumoniae Gram-negative, non-motile, capsulated, gas-producing rods found widely in nature and associated with urinary and respiratory infections in humans. Bacillus pneumoniae,Bacterium pneumoniae crouposae,Hyalococcus pneumoniae,Klebsiella pneumoniae aerogenes,Klebsiella rhinoscleromatis
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D011634 Public Health Branch of medicine concerned with the prevention and control of disease and disability, and the promotion of physical and mental health of the population on the international, national, state, or municipal level. Community Health,Environment, Preventive Medicine & Public Health,Environment, Preventive Medicine and Public Health,Health, Community,Health, Public
D001938 Brazil A country located on the eastern coast of South America, located between Colombia and Peru, that borders the Atlantic Ocean. It is bordered on the north by Venezuela, Guyana, Suriname, and French Guiana, on the south by Uruguay, and on the west by Argentina. The capital is Brasilia.
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003428 Cross Infection Any infection which a patient contracts in a health-care institution. Hospital Infections,Nosocomial Infections,Health Care Associated Infection,Health Care Associated Infections,Healthcare Associated Infections,Infection, Cross,Infections, Hospital,Infections, Nosocomial,Cross Infections,Healthcare Associated Infection,Hospital Infection,Infection, Healthcare Associated,Infection, Hospital,Infection, Nosocomial,Infections, Cross,Infections, Healthcare Associated,Nosocomial Infection
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001426 Bacterial Proteins Proteins found in any species of bacterium. Bacterial Gene Products,Bacterial Gene Proteins,Gene Products, Bacterial,Bacterial Gene Product,Bacterial Gene Protein,Bacterial Protein,Gene Product, Bacterial,Gene Protein, Bacterial,Gene Proteins, Bacterial,Protein, Bacterial,Proteins, Bacterial

Related Publications

Jorge A Ramos-Castañeda, and Alberto Ruano-Ravina, and Raquel Barbosa-Lorenzo, and Jaime E Paillier-Gonzalez, and Javier C Saldaña-Campos, and Diego F Salinas, and Elkin V Lemos-Luengas
October 2009, F1000 medicine reports,
Jorge A Ramos-Castañeda, and Alberto Ruano-Ravina, and Raquel Barbosa-Lorenzo, and Jaime E Paillier-Gonzalez, and Javier C Saldaña-Campos, and Diego F Salinas, and Elkin V Lemos-Luengas
June 2012, Expert opinion on biological therapy,
Jorge A Ramos-Castañeda, and Alberto Ruano-Ravina, and Raquel Barbosa-Lorenzo, and Jaime E Paillier-Gonzalez, and Javier C Saldaña-Campos, and Diego F Salinas, and Elkin V Lemos-Luengas
February 2015, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
Jorge A Ramos-Castañeda, and Alberto Ruano-Ravina, and Raquel Barbosa-Lorenzo, and Jaime E Paillier-Gonzalez, and Javier C Saldaña-Campos, and Diego F Salinas, and Elkin V Lemos-Luengas
January 2015, Future microbiology,
Jorge A Ramos-Castañeda, and Alberto Ruano-Ravina, and Raquel Barbosa-Lorenzo, and Jaime E Paillier-Gonzalez, and Javier C Saldaña-Campos, and Diego F Salinas, and Elkin V Lemos-Luengas
January 2019, Journal of chemotherapy (Florence, Italy),
Jorge A Ramos-Castañeda, and Alberto Ruano-Ravina, and Raquel Barbosa-Lorenzo, and Jaime E Paillier-Gonzalez, and Javier C Saldaña-Campos, and Diego F Salinas, and Elkin V Lemos-Luengas
February 2018, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
Jorge A Ramos-Castañeda, and Alberto Ruano-Ravina, and Raquel Barbosa-Lorenzo, and Jaime E Paillier-Gonzalez, and Javier C Saldaña-Campos, and Diego F Salinas, and Elkin V Lemos-Luengas
January 2021, The Journal of antimicrobial chemotherapy,
Jorge A Ramos-Castañeda, and Alberto Ruano-Ravina, and Raquel Barbosa-Lorenzo, and Jaime E Paillier-Gonzalez, and Javier C Saldaña-Campos, and Diego F Salinas, and Elkin V Lemos-Luengas
January 2020, IDCases,
Jorge A Ramos-Castañeda, and Alberto Ruano-Ravina, and Raquel Barbosa-Lorenzo, and Jaime E Paillier-Gonzalez, and Javier C Saldaña-Campos, and Diego F Salinas, and Elkin V Lemos-Luengas
October 2023, The Journal of antimicrobial chemotherapy,
Jorge A Ramos-Castañeda, and Alberto Ruano-Ravina, and Raquel Barbosa-Lorenzo, and Jaime E Paillier-Gonzalez, and Javier C Saldaña-Campos, and Diego F Salinas, and Elkin V Lemos-Luengas
August 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Copied contents to your clipboard!